Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Longeveron Inc (NQ: LGVN )

1.715 -0.035 (-2.00%)
Streaming Delayed Price Updated: 11:43 AM EDT, May 6, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Longeveron Inc

< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Should Aging Be Treated As A Disease? And How One Company Might Be Shifting The Paradigm To Reverse It
Technical advancements in stem cell therapies have reportedly shifted the outlook of regenerative medicine, and some scientists are getting increasingly excited. 
Via Benzinga
How to Buy Stocks in a Recession
The same strategies for buying stocks during a bull market don't apply during a recession. Learn what you need to do going forward. 
Via InvestorPlace
The Daily Biotech Pulse: FDA Orphan Drug Tags For Neurocrine, Editas Candidates; Sale of BridgeBio's PRV; RMAT Designation For PolarityTE's Product
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap: Longeveron Q1 Earnings
Longeveron (NASDAQ:LGVN) reported its Q1 earnings results on Friday, May 13, 2022 at 08:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Earnings Scheduled For May 13, 2022
Companies Reporting Before The Bell • Codere Online Luxembourg (NASDAQ:CDRO) is estimated to report quarterly loss at $0.13 per share on revenue of $20.08 million. 
Via Benzinga
Longeveron's Earnings: A Preview
Longeveron (NASDAQ:LGVN) is set to give its latest quarterly earnings report on Friday, 2022-05-13. Here's what investors need to know before the announcement. Analysts estimate that Longeveron will... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
With the start of another day comes our breakdown of the biggest pre-market stock movers and this time it's for Thursday! 
Via InvestorPlace
The Daily Biotech Pulse: Pfizer Acquires Migraine Drugmaker For $11B, Biogen Files For Second Alzheimer's Drug Approval, Longeveron CEO Leaves
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Follow the Insiders and Buy the Dip in These 3 Stocks
These three biotech companies have all had insiders buying shares recently. That's a good sign for the future of their treatments. 
Via InvestorPlace
Analyzing Longeveron Inc. - common stock's Short Interest
Longeveron Inc. - common stock's (NASDAQ:LGVN) short percent of float has risen 35.04% since its last report. The company recently reported that it has 746.20 thousand shares sold... 
Via Benzinga
71 Biggest Movers From Yesterday
Gainers Evoke Pharma, Inc. (NASDAQ: EVOK) shares jumped 118.5% to close at $0.86 on Tuesday. The FDA granted new drug product exclusivity to Evoke Pharma's Gimoti (... 
Via Benzinga
Longeveron Partners With US Department Of Veterans Affairs For Its Phase 2 Alzheimer's Trial
Photo by Caleb Fisher on Unsplash 
Via Benzinga
53 Biggest Movers From Yesterday
Gainers ION Geophysical Corporation (NYSE: IO) shares surged 91.2% to settle at $0.6980 on Wednesday. ION Geophysical was awarded a five-year contract by Brunei Shell Petroleum... 
Via Benzinga
Cognitive Drugs Market Expected Reach Revenues Of $21 Billion in 2027
Palm Beach, FL – April 13, 2022 – FinancialNewsMedia.com News Commentary – Dementia is the loss of cognitive functioning, thinking, remembering, reasoning, and behavioral abilities to such an extent... 
Via FinancialNewsMedia
Exposures COVID-19
EXCLUSIVE: Longeveron Adds Miami Veterans Affairs Site To Its Ongoing Mid-Stage Alzheimer's Trial
Longeveron Inc (NASDAQ: LGVN) has announced a Cooperative Research and Development Agreement (CRADA) with the United States Department of Veterans Affairs (VA) to add Miami VA clinical site to its... 
Via Benzinga
5 Short Squeeze Candidates To Watch: Aterian Tops The List, System1 Group And Longeveron Join Leaderboard
Potential short squeeze plays gained steam in 2021, with new retail traders looking for the next huge move. A short squeeze can occur when a heavily shorted stock rises in value... 
Via Benzinga
Recession Fears are Creating a Golden Opportunity for Biotech Stocks
Biotech stocks are hard for novice investors to successfully profit from, but it's worth your time to learn the techniques now. 
Via InvestorPlace
A Peek Into The Markets: US Stock Futures Down Ahead Of Fed Minutes
Pre-open movers 
Via Benzinga
5 Stocks To Watch For April 6, 2022
Some of the stocks that may grab investor focus today are: Wall Street expects RPM International Inc. (NYSE: RPM) to report quarterly earnings at $0.30 per share on revenue of $1.41 million before the... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Gainers Sunshine Biopharma (NASDAQ:SBFM) shares rose 141.5% to $5.46 during Tuesday's regular session. Trading volume for this security as of 13:30 EST is 114.7... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Good morning, investor! It's time to start off another busy day of trading with the biggest pre-market stock movers for Tuesday! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Cognition Therapeutics (NASDAQ:CGTX) shares increased by 26.2% to $3.28 during Monday's regular session. Trading volume for Cognition Therapeutics's stock... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Aterian, Inc. (NASDAQ: ATER) shares jumped 43.5% to $3.3457. Aterian said Cynthia Williams has joined the Company's Board of Directors. Jumia Technologies AG (... 
Via Benzinga
68 Biggest Movers From Yesterday
Gainers GBS Inc. (NASDAQ: GBS) jumped 68% to settle at $1.31 on Monday. Zacks Small-Cap Research issued a note on GBS with an $8 valuation. Aterian, Inc. (NASDAQ: ATER) shares... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
  
Via Benzinga
The Week Ahead In Biotech (April 3-April 9): BioXcel FDA Decision, Neurology Conference Presentations Take The Spotlight
Biopharma stocks outperformed the broader market in the week ending April 2, thereby recouping the losses from the previous week. Clinical readouts and FDA decisions were among the chief catalysts that... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Yumanity Therapeutics (NASDAQ:YMTX) shares rose 13.3% to $1.7 during Friday's pre-market session. The market value of their outstanding shares is at $18.4... 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday
Good morning, investor! It's the last trading day of the week and that means it's time to get into the pre-market stock movers for Friday! 
Via InvestorPlace
21 Stocks Moving in Friday's Pre-Market Session
Gainers Blackboxstocks Inc. (NASDAQ: BLBX) rose 37.6% to $3.69 in pre-market trading after the company reported better-than-expected Q4 sales results. Chicken Soup for the Soul... 
Via Benzinga
53 Biggest Movers From Yesterday
Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing... 
Via Benzinga
< Previous 1 2
...
6 7 8 9 10 11 12 13 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.